{"id":1428,"date":"2026-02-04T14:14:53","date_gmt":"2026-02-04T14:14:53","guid":{"rendered":"https:\/\/www.doctaforum-events.org\/2026\/ibc2026\/?page_id=1428"},"modified":"2026-02-04T14:14:53","modified_gmt":"2026-02-04T14:14:53","slug":"friday-february-13th","status":"publish","type":"page","link":"https:\/\/www.doctaforum-events.org\/2026\/ibc2026\/friday-february-13th\/","title":{"rendered":"Friday, February 13th"},"content":{"rendered":"<div class=\"panel-pagina\">\n<div class=\"panel-group\">\n<div class=\"panel\">\n<div class=\"panel-heading\">\n<div class=\"panel_hour\">\n<h4 class=\"panel-title\">16:30 &#8211; 17:50<\/h4>\n<\/p><\/div>\n<div class=\"title_panel\">\n<h4 class=\"panel-title\">\n                        <span class=\"session-label\">SESI\u00d3N 3:<\/span><br \/>\n                        <span class=\"session-title\">General Topic 2<\/span><br \/>\n                    <\/h4>\n<\/p><\/div>\n<\/p><\/div>\n<div id=\"collapse3\" class=\"panel-collapse collapse in\">\n                \n<table id=\"tablepress-10\" class=\"tablepress tablepress-id-10\">\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-1\">\n\t<td class=\"column-1\"><span class=\"chair\">Chair:<\/span><br \/>\n<\/td><td class=\"column-2\"><br \/>\n<span class=\"clase2\">Carlos Barrios, <\/span><span class=\"clase3\">Latin American Cooperative Oncology Group, Porto Alegre, Brazil<\/span><\/td>\n<\/tr>\n<tr class=\"row-2\">\n\t<td class=\"column-1\">16:30 - 16:50<\/td><td class=\"column-2\"><span class=\"clase1\">ctDNA monitoring of residual disease to guide adjuvant therapy in early breast cancer<\/span><br \/>\n<br \/>\n<span class=\"clase2\">Isaac Garc\u00eda Murillas, <\/span><span class=\"clase3\">The Institute of Cancer Research, London, UK<\/span><\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">16:50 - 17:10<\/td><td class=\"column-2\"><span class=\"clase1\">Guiding therapy with blood based biomarkers in advanced breast cancer<\/span><br \/>\n<br \/>\n<span class=\"clase2\">Angel Guerrero, <\/span><span class=\"clase3\">Instituto Valenciano de Oncolog\u00eda, Spain<\/span><\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">17:10 - 17:30<\/td><td class=\"column-2\"><span class=\"clase1\">Immune-mediated resistance to CDK4\/6 inhibitors<\/span><br \/>\n<br \/>\n<span class=\"clase2\">Giulia Petroni, <\/span><span class=\"clase3\">Department of Experimental and Clinical Medicine,<br \/>\nUniversity of Florence, Italy<\/span><\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">17:30 - 17:50<\/td><td class=\"column-2\"><span class=\"clase1\">Discussion<\/span><\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">17:50 - 18:00<\/td><td class=\"column-2\"><span class=\"clase4\">Break<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n            <\/div>\n<\/p><\/div>\n<div class=\"panel2\">\n<div class=\"panel-heading coloramarillo\">\n<div class=\"panel_hour\">\n<h4 class=\"panel-title\">18:00 &#8211; 19:20<\/h4>\n<\/p><\/div>\n<div class=\"title_panel\">\n<h4 class=\"panel-title\">\n                        <span class=\"session-label\">SESI\u00d3N 4:<\/span><br \/>\n                        <span class=\"session-title\">Therapy 2<\/span><br \/>\n                    <\/h4>\n<\/p><\/div>\n<\/p><\/div>\n<div id=\"collapse4\" class=\"panel-collapse collapse in\">\n                \n<table id=\"tablepress-12\" class=\"tablepress tablepress-id-12\">\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-1\">\n\t<td class=\"column-1\"><span class=\"chair\">Chair:<\/span><\/td><td class=\"column-2\"><br \/>\n<span class=\"clase2\">Sara L\u00f3pez Tarruella, <\/span><span class=\"clase3\">Hospital General Universitario Gregorio Mara\u00f1on, Madrid, Spain<\/span><\/td>\n<\/tr>\n<tr class=\"row-2\">\n\t<td class=\"column-1\">18:00 - 18:20<\/td><td class=\"column-2\"><span class=\"clase1\">Therapeutic approach after resistance to CDK4\/6 inhibition<\/span><br \/>\n<br \/>\n<span class=\"clase2\">Miguel Martin, <\/span><span class=\"clase3\">Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Universidad Complutense de Madrid, Spain<\/span><\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">18:20 - 18:40<\/td><td class=\"column-2\"><span class=\"clase1\">Antibody-drug conjugates for triple negative advanced breast cancer<\/span><br \/>\n<br \/>\n<span class=\"clase2\">Sara M Tolaney, <\/span><span class=\"clase3\">Dana Farber Cancer Institute, Boston, USA<\/span><\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">18:40 - 19:00<\/td><td class=\"column-2\"><span class=\"clase1\">Maintenance strategies in HER2-positive advanced breast cancer<\/span><br \/>\n<br \/>\n<span class=\"clase2\">Veronique Dieras, <\/span><span class=\"clase3\">Centre Eug\u00e8ne Marquis, Rennes, France<\/span><\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">19:00 - 19:20<\/td><td class=\"column-2\"><span class=\"clase1\">Discussion<\/span><\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">19:20 - 19:30<\/td><td class=\"column-2\"><span class=\"clase4\">CLOSING REMARKS<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n            <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>16:30 &#8211; 17:50 SESI\u00d3N 3: General Topic 2 18:00 &#8211; 19:20 SESI\u00d3N 4: Therapy 2<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1428","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/ibc2026\/wp-json\/wp\/v2\/pages\/1428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/ibc2026\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/ibc2026\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2026\/ibc2026\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2026\/ibc2026\/wp-json\/wp\/v2\/comments?post=1428"}],"version-history":[{"count":1,"href":"https:\/\/www.doctaforum-events.org\/2026\/ibc2026\/wp-json\/wp\/v2\/pages\/1428\/revisions"}],"predecessor-version":[{"id":1429,"href":"https:\/\/www.doctaforum-events.org\/2026\/ibc2026\/wp-json\/wp\/v2\/pages\/1428\/revisions\/1429"}],"wp:attachment":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/ibc2026\/wp-json\/wp\/v2\/media?parent=1428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}